MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 158 filers reported holding MERSANA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $41,380 | +12.9% | 20,587 | +30.3% | 0.00% | – |
| Q4 2023 | $36,656 | +633.1% | 15,800 | +1244.7% | 0.00% | – |
| Q1 2023 | $5,000 | -95.3% | 1,175 | -93.5% | 0.00% | – |
| Q4 2022 | $107,000 | -29.1% | 18,175 | -18.5% | 0.00% | -100.0% |
| Q3 2022 | $151,000 | +480.8% | 22,300 | +35.2% | 0.00% | – |
| Q3 2019 | $26,000 | -72.3% | 16,500 | -29.2% | 0.00% | -100.0% |
| Q2 2019 | $94,000 | – | 23,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $28,503,484 | 2.94% |
| Logos Global Management LP | 2,800,000 | $9,212,000 | 1.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,100,000 | $3,619,000 | 1.12% |
| 5AM Venture Management, LLC | 1,305,000 | $4,293,450 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $3,290,000 | 1.02% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $2,975,042 | 0.93% |
| Sarissa Capital Management LP | 2,632,900 | $8,662,241 | 0.86% |
| DAFNA Capital Management LLC | 810,845 | $2,667,680 | 0.73% |
| Tri Locum Partners LP | 428,307 | $1,409,130 | 0.52% |
| Avidity Partners Management LP | 3,790,000 | $12,469,100 | 0.44% |